IL139297A0 - Imidazo pyridine derivatives which inhibit gastric acid secretion - Google Patents

Imidazo pyridine derivatives which inhibit gastric acid secretion

Info

Publication number
IL139297A0
IL139297A0 IL13929799A IL13929799A IL139297A0 IL 139297 A0 IL139297 A0 IL 139297A0 IL 13929799 A IL13929799 A IL 13929799A IL 13929799 A IL13929799 A IL 13929799A IL 139297 A0 IL139297 A0 IL 139297A0
Authority
IL
Israel
Prior art keywords
gastric acid
acid secretion
pyridine derivatives
inhibit gastric
imidazo pyridine
Prior art date
Application number
IL13929799A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL139297A0 publication Critical patent/IL139297A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13929799A 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion IL139297A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds
PCT/SE1999/000663 WO1999055706A1 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion

Publications (1)

Publication Number Publication Date
IL139297A0 true IL139297A0 (en) 2001-11-25

Family

ID=20411154

Family Applications (4)

Application Number Title Priority Date Filing Date
IL13929799A IL139297A0 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion
IL13920099A IL139200A0 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion
IL139200A IL139200A (en) 1998-04-29 2000-10-23 GASTRIC ACID SECRETION INHIBITING (N - SUBSTITUTED) IMIDAZO [1,2 - a] PYRIDINE - 6 - CARBOXAMIDES CARRYING A BENZYL GROUP IN POSITION 8, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME INTERMEDIATES THEREFOR
IL139297A IL139297A (en) 1998-04-29 2000-10-26 Derivatives of imidazo pyridine that inhibit gastric acid secretion

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL13920099A IL139200A0 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion
IL139200A IL139200A (en) 1998-04-29 2000-10-23 GASTRIC ACID SECRETION INHIBITING (N - SUBSTITUTED) IMIDAZO [1,2 - a] PYRIDINE - 6 - CARBOXAMIDES CARRYING A BENZYL GROUP IN POSITION 8, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME INTERMEDIATES THEREFOR
IL139297A IL139297A (en) 1998-04-29 2000-10-26 Derivatives of imidazo pyridine that inhibit gastric acid secretion

Country Status (33)

Country Link
US (2) US6313136B1 (cs)
EP (4) EP1073656B1 (cs)
JP (2) JP3883383B2 (cs)
KR (3) KR100650472B1 (cs)
CN (2) CN1165535C (cs)
AR (2) AR015769A1 (cs)
AT (4) ATE372340T1 (cs)
AU (2) AU769190B2 (cs)
BR (2) BR9909996B1 (cs)
CA (2) CA2329922C (cs)
CZ (2) CZ292567B6 (cs)
DE (4) DE69927803T2 (cs)
DK (2) DK1073657T3 (cs)
EE (2) EE04916B1 (cs)
ES (2) ES2249913T3 (cs)
HU (2) HUP0102313A3 (cs)
ID (2) ID27530A (cs)
IL (4) IL139297A0 (cs)
IS (2) IS5684A (cs)
MY (2) MY121379A (cs)
NO (2) NO318203B1 (cs)
NZ (2) NZ507638A (cs)
PL (2) PL195000B1 (cs)
RU (2) RU2238271C2 (cs)
SA (2) SA99200064B1 (cs)
SE (1) SE9801526D0 (cs)
SI (1) SI1073656T1 (cs)
SK (2) SK285768B6 (cs)
TR (4) TR200003176T2 (cs)
TW (2) TW490466B (cs)
UA (2) UA66846C2 (cs)
WO (2) WO1999055706A1 (cs)
ZA (2) ZA200005796B (cs)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
NZ526993A (en) * 2001-02-13 2005-01-28 Astrazeneca Ab Pharmaceutical formulation of a drug substance that has a pH-dependent solubility in water
BR0207762A (pt) * 2001-03-08 2004-06-01 Astrazeneca Ab Uso de um composto ou um sal farmaceuticamente aceitável do mesmo, combinação, formulação farmacêutica, kit, método para a prevenção da úlcera gástrica induzida por medicamento, e, composição farmacêutica oral
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
KR20050052500A (ko) 2002-09-19 2005-06-02 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 이미다조피리딘
NZ540504A (en) 2002-11-19 2007-12-21 Altana Pharma Ag 8-Substituted imidazopyridines for the treatment of gastrointestinal disorders
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
NZ541861A (en) * 2003-02-26 2009-05-31 Sugen Inc Aminoheteroaryl compounds as protein kinase inhibitors
BRPI0406427B8 (pt) 2003-03-10 2021-05-25 Astrazeneca Ab processo para a preparação de roflumilast
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN1874772A (zh) * 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1838309B1 (en) * 2004-12-17 2008-08-20 Pfizer, Inc. Chromane derivatives useful as acid pump antagonists
US8663694B2 (en) 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
MY147647A (en) * 2005-03-21 2012-12-31 S Bio Pte Ltd Imidazo [1,2-a] pyridine derivatives : preparation and pharmaceutical applications
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
AR055321A1 (es) * 2005-03-24 2007-08-15 Glaxo Group Ltd Compuestos de imidazopiridina uso para a fabricacion de un medicamento para el tratamiento o profilaxis de enfermedades o trastornos en los que se requiere un antagonista de una bomba de acido y composicion farmaceutica que lo comprende
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
KR101146852B1 (ko) 2005-12-05 2012-05-16 화이자 프로덕츠 인크. C?met/hgfr 억제제의 다형체
US7825137B2 (en) 2005-12-05 2010-11-02 Pfizer Inc. Method of treating abnormal cell growth
BRPI0708808A2 (pt) * 2006-03-17 2011-06-14 Raqualia Pharma Inc Derivados de cromano
EP2054036B1 (en) 2006-07-24 2019-12-18 Singh-Broemer and Company, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
WO2009122435A2 (en) * 2008-03-31 2009-10-08 Council Of Scientific & Industrial Research A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
RU2403904C1 (ru) * 2009-02-26 2010-11-20 Федеральное государственное учреждение "Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию Росздрава" Способ профилактики острых гастродуоденальных язв у больных колоректальным раком в раннем послеоперационном периоде
EP2452680B1 (en) * 2009-07-09 2019-12-18 RaQualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
KR102314290B1 (ko) * 2013-06-25 2021-10-21 에프. 호프만-라 로슈 아게 척수성 근위축증을 치료하기 위한 화합물
CN106029660B (zh) 2013-12-16 2019-11-15 阿萨纳生物科技有限责任公司 P2x3和/或p2x2/3化合物和方法
DK3122748T3 (en) * 2014-03-24 2018-11-05 Arqule Inc METHOD OF PREPARING 3- (3- (4- (1-AMINOCYCLOBUTYL) PHENYL) -5-PHENYL-3H-IMIDAZO [4,5-B] PYRIDIN-2-YL) PYRIDIN-2-AMINE
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) * 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
WO2019152977A2 (en) 2018-02-05 2019-08-08 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
CN112004795A (zh) 2018-04-10 2020-11-27 拜耳公司 制备2,6-二烷基苯乙酸的方法
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
ES2949232T3 (es) 2019-11-04 2023-09-26 Cinclus Pharma Holding Ab Publ Formulación Oral de X842
EP4426694A1 (en) 2021-11-05 2024-09-11 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
WO2023079093A1 (en) 2021-11-05 2023-05-11 Cinclus Pharma Holding AB (publ) Polymorphs of the mesylate salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
KR20250130654A (ko) 2023-01-11 2025-09-02 싱클루스 파마 홀딩 에이비 (피유비엘) 리나프라잔 글루레이트의 말레산 염의 다형체
KR20250132529A (ko) 2023-01-11 2025-09-04 싱클루스 파마 홀딩 에이비 (피유비엘) 리나프라잔 글루레이트의 하이드로브로마이드 염의 다형체
IL322434A (en) * 2023-02-01 2025-09-01 Jeil Pharmaceutical Co Ltd Pharmaceutical formulation, method of preparation and tablet composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
GB9107513D0 (en) * 1991-04-10 1991-05-29 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof

Also Published As

Publication number Publication date
DK1073656T3 (da) 2006-01-16
SK285768B6 (sk) 2007-07-06
ATE312101T1 (de) 2005-12-15
ID26819A (id) 2001-02-15
DE69937076T2 (de) 2008-05-29
ES2252975T3 (es) 2006-05-16
HK1033457A1 (en) 2001-08-31
AU4300699A (en) 1999-11-16
IL139200A (en) 2010-04-29
EE200000626A (et) 2002-04-15
SE9801526D0 (sv) 1998-04-29
SA99200064B1 (ar) 2006-10-11
BR9909995A (pt) 2000-12-26
IS5684A (is) 2000-10-25
BR9909996B1 (pt) 2010-08-24
SA99200065B1 (ar) 2006-11-07
SK14912000A3 (sk) 2001-06-11
EP1073657A1 (en) 2001-02-07
CN1165535C (zh) 2004-09-08
AR015769A1 (es) 2001-05-16
NO318203B1 (no) 2005-02-14
CN1306533A (zh) 2001-08-01
EP1073656A1 (en) 2001-02-07
NO20005450D0 (no) 2000-10-27
NO317262B1 (no) 2004-09-27
CN1307577A (zh) 2001-08-08
RU2238271C2 (ru) 2004-10-20
RU2235725C2 (ru) 2004-09-10
CA2329921A1 (en) 1999-11-04
ATE307130T1 (de) 2005-11-15
JP3883383B2 (ja) 2007-02-21
ZA200005797B (en) 2002-01-18
EP1491543B1 (en) 2007-09-05
KR100650472B1 (ko) 2006-11-28
UA66846C2 (uk) 2004-06-15
TR200102612T2 (tr) 2002-06-21
KR100595806B1 (ko) 2006-07-03
US6313136B1 (en) 2001-11-06
KR20010043133A (ko) 2001-05-25
EE04916B1 (et) 2007-10-15
NO20005451D0 (no) 2000-10-27
ID27530A (id) 2001-04-12
CZ20003981A3 (cs) 2001-03-14
KR20010043134A (ko) 2001-05-25
JP2002513025A (ja) 2002-05-08
HUP0102313A3 (en) 2002-10-28
TR200003176T2 (tr) 2001-03-21
MY121379A (en) 2006-01-28
DE69928792D1 (de) 2006-01-12
ZA200005796B (en) 2002-01-18
AU4300799A (en) 1999-11-16
HK1033317A1 (en) 2001-08-24
AU769190B2 (en) 2004-01-22
DK1073657T3 (da) 2006-03-13
HUP0102425A3 (en) 2002-12-28
NZ507639A (en) 2004-01-30
DE69928792T2 (de) 2006-07-20
WO1999055706A9 (en) 2000-03-16
HK1036981A1 (en) 2002-01-25
DE69927803D1 (de) 2006-03-02
ES2249913T3 (es) 2006-04-01
HUP0102313A2 (hu) 2001-12-28
PL343797A1 (en) 2001-09-10
CA2329922C (en) 2006-04-11
EP1491543A1 (en) 2004-12-29
TR200003149T2 (tr) 2001-03-21
NO20005451L (no) 2000-12-27
HK1071139A1 (en) 2005-07-08
EP1491542A3 (en) 2005-01-05
US6313137B1 (en) 2001-11-06
DE69937076D1 (de) 2007-10-18
CZ292567B6 (cs) 2003-10-15
HK1036984A1 (en) 2002-01-25
AR015768A1 (es) 2001-05-16
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
ATE372340T1 (de) 2007-09-15
IL139297A (en) 2007-06-03
TWI250159B (en) 2006-03-01
CA2329922A1 (en) 1999-11-04
AU769108B2 (en) 2004-01-15
IL139200A0 (en) 2001-11-25
JP2002513024A (ja) 2002-05-08
NZ507638A (en) 2003-10-31
DE69937077T2 (de) 2008-05-29
CN1174980C (zh) 2004-11-10
SK14922000A3 (sk) 2001-06-11
EE04676B1 (et) 2006-08-15
PL343801A1 (en) 2001-09-10
UA67769C2 (uk) 2004-07-15
PL195000B1 (pl) 2007-07-31
TW490466B (en) 2002-06-11
KR100595805B1 (ko) 2006-07-03
DE69937077D1 (de) 2007-10-18
MY121389A (en) 2006-01-28
EP1073656B1 (en) 2005-10-19
ATE372339T1 (de) 2007-09-15
TR200102728T2 (tr) 2002-06-21
WO1999055705A1 (en) 1999-11-04
BR9909995B1 (pt) 2010-07-13
HUP0102425A2 (hu) 2001-11-28
KR20050121760A (ko) 2005-12-27
CZ20003982A3 (cs) 2001-02-14
IS5683A (is) 2000-10-25
BR9909996A (pt) 2000-12-26
SA99200065A (ar) 2005-12-03
JP3692034B2 (ja) 2005-09-07
CZ293977B6 (cs) 2004-09-15
EP1491542A2 (en) 2004-12-29
NO20005450L (no) 2000-12-22
EE200000664A (et) 2002-04-15
EP1491542B1 (en) 2007-09-05
EP1073657B1 (en) 2005-12-07
DE69927803T2 (de) 2006-07-06

Similar Documents

Publication Publication Date Title
PL343801A1 (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
IL140358A0 (en) Aminomethylarboxylic acid derivatives
SI1129088T1 (sl) Kristalinična oblika (R)-2(((3-metil-4-(2,2,2-trifluoroetoksi)-2-piridinil)metil)sulfinil)- 1H-benzimidazola
EE04016B1 (et) Ühendid maohappesekretsiooni inhibeerimiseks
PL354600A1 (en) Naphthyridine derivatives
SI1105391T1 (en) Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation
HU9302741D0 (en) Gastric acid secretion inhibiting new pyrrolo[2,3-b]pyridine derivatives
AP9901457A0 (en) Novel dihydroxyexanoic acid derivatives
IL148031A0 (en) Torsemide polymorphs
AU1056302A (en) Polysubstituted imidazopyridines as gastric secretion inhibitors
IL131644A0 (en) Process for the preparation of nicotinic acid
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
GB9925457D0 (en) Gastric acid secretion
HU9900194D0 (en) Process for the preparation of pyridine dicarboxylate-derivatives
GB9705031D0 (en) 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives
SI1073657T1 (sl) Imidazo piridinski derivati, ki inhibirajo izlocanje zelodcne kisline
IL128611A0 (en) Process for the preparation of substituted pyridines
SI1105390T1 (en) Imidazo(1,2-a)pyridine derivatives for the treatment of gastrointestinal diseases
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed